Arbutin attenuates CFA-induced arthritis by modulating expression levels of 5-LOX, NF‑κB, IL-17, PGE-2 and TNF-α
Inflammopharmacology · 2024
DOI: 10.1007/s10787-024-01480-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammopharmacology, 2024. Verfasst von Nabeela Tabassum Sial und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, College of Pharmacy, University of Sargodha, Sargodha, 40100, Pakistan. Hauptthemen laut MEDLINE: NF-kappa B, Arthritis, Experimental, Arbutin, Tumor Necrosis Factor-alpha. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 56 Literaturangaben.
Abstract (Originalsprache)
Arbutin, a naturally soluble glycosylated phenol has antioxidant, antimicrobial, antitumor and anti-inflammatory properties. The current exploration appraises the treatment of arthritis by use of Arbutin (25, 50 and 100 mg/kg) orally in CFA-induced rat arthritis model. Body weight changes, paw size, and joint diameter were recorded till the 28th day in the arthritic-induced rats. Hematological, biochemical, oxidative and inflammatory biomarkers were measured through the blood samples of anesthetized rats. Arbutin markedly decreased paw volume, PGE-2, anti-CCP and 5-LOX levels, however, maintained metabolic and hematological balance and prevented weight loss. Radiology and histology changes improved significantly in the ankle joints of rats. Moreover, Arbutin increased gene pointers such as IL-10 and IL-4 while significantly reducing the levels of CRP and WBCs, whereas Hb, platelets and RBCs count markedly raised in post-treatments. Antioxidant levels of SOD, CAT and GSH were improved and MDA level was reduced in treated groups. Rt-PCR investigation showed a significant reduction of the interleukin-1β, TNF-α, interleukin-6, cyclooxygenase-2, NF-κB and IL-17 and increased expression of gene pointers like IL-4, and IL-10 in treated groups. Assessment of molecular docking revealed a strong binding interaction of Arbutin against 5-LOX, IL-17, TNF-alpha and interleukin-6, cyclooxygenase-2, nuclear factor-κB, IL-4 and iNOS providing a strong association between experimental and theoretical results. As a result, Arbutin has significantly reduced CFA-induced arthritis by modulation of anti-inflammatory cytokines, i.e., IL-10 and IL-4, the pro-inflammatory cytokines panel such as NF-κB, TNF-alpha, IL-1β, IL-6, PGE-2, 5-LOX and COX-2 and oxidative biomarkers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, College of Pharmacy, University of Sargodha, Sargodha, 40100, Pakistan.
- Department of Pharmacology, Institute of Pharmacy, Faculty of Pharmaceutical and Allied Health Sciences, Lahore College for Women University, Jail Road, Lahore, 54000, Pakistan.
- Department of Pharmacology, College of Pharmacy, University of Sargodha, Sargodha, 40100, Pakistan. abdul.malik@uos.edu.pk.
- Institute of Chemistry, University of Sargodha, Sargodha, 40100, Pakistan.
Zitieren
APA
Sial, N. T., Malik, A., Iqbal, U., & Rehman, M. F. U. (2024). Arbutin attenuates CFA-induced arthritis by modulating expression levels of 5-LOX, NF‑κB, IL-17, PGE-2 and TNF-α. Inflammopharmacology. https://doi.org/10.1007/s10787-024-01480-5
Vancouver
Sial NT, Malik A, Iqbal U, Rehman MFU. Arbutin attenuates CFA-induced arthritis by modulating expression levels of 5-LOX, NF‑κB, IL-17, PGE-2 and TNF-α. Inflammopharmacology. 2024. doi:10.1007/s10787-024-01480-5
BibTeX
@article{Sial2024,
author = {Sial, Nabeela Tabassum and Malik, Abdul and Iqbal, Urooj and Rehman, Muhammad Fayyaz Ur},
title = {Arbutin attenuates CFA-induced arthritis by modulating expression levels of 5-LOX, NF‑κB, IL-17, PGE-2 and TNF-α},
journal = {Inflammopharmacology},
year = {2024},
doi = {10.1007/s10787-024-01480-5}
}
EUVIMED